Skip to content

First Tracks Biotherapeutics, Inc.

TRAX· NasdaqCore metricsCIK 2091349

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -3.59%
Market cap
$2.05B
42.02M shares
Filings
100
—
—
—
-$31.36M
Q3 2026
—
-$32.84M
Q3 2026
—
-$81.57M
Q3 2026derived
—
-$0.88
Q3 2026
—
$155.63M
Q3 2026+93.5% FY25 yoy
$2.05B
—
—
13.6×
—
—

FY2026 figures · derived

Price

$48.73+161.96%+$30.13since Apr 20, 2026
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Research And Development

$23.85MQ3 2026
No annual history for this metric yet.
PeriodEndedValueKindSource trail

Pharmaceutical preparations

First Tracks Biotherapeutics, Inc. is the 94th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

First Tracks Biotherapeutics, Inc. · CIK 2091349 · Engraved from SEC EDGAR